Dhiraj kumar
@dhirajverma
Researcher !!! #TB #Autophagy
The future of India’s biotech industry includes developing biopharmaceuticals and smart proteins, transitioning to a bio-based economy, and utilizing waste for bio-production. These advancements aim to support the goal of Net Zero Carbon Emissions and create employment…
Tuberculosis bacteria hijack our gene expression—latest study from our #CellularImmunologyGroup reveals how Mtb rewires RNA splicing to outsmart our immune system. Watch the video here ! You can access the full paper here:: pnas.org/doi/10.1073/pn…
#NewResearch Alert ! New study from #CellularImmunologyGroup @ICGEBNewDelhi, uncovers how Mycobacterium tuberculosis hijacks host RNA splicing to weaken immune defenses. Disabling this mechanism significantly impairs bacterial survival. Stay tuned-in for a video explainer, which…
pnas.org/doi/10.1073/pn… Latest from the lab. @ICGEB @ICGEBNewDelhi @DBTIndia Excellent collaboration with Vinay @ccmb_csir @aiims_newdelhi and @Lab_AmitSinghal Thanks to support from @India_Alliance
On #WorldTBDay, held at Vigyan Bhavan, Dr. Dhiraj Kumar, Group Leader, Cellular Immunology Group @ICGEBNewDelhi providing an insightful briefing on the role of @ICGEBNewDelhi as a key partner in the Tuberculosis Genomic Surveillance Consortium (InTGS)—a joint initiative by the…
Applications are open for the 2025 FluoMicro course @ICGEBNewDelhi! Last date of application: 20th March. @ICGEB icgeb.org/fluomicroicgeb…
Submit your Abstract before 20th October. Many slots for short talks from selected abstracts! #tuberculosis #EMBOtuberculosis @CSIR_IND @DBTIndia @ICMRDELHI
Deadline for Abstract Submission and Registration: 20th October 2024! #EMBOtuberculosis @ccmb_csir @ICGEBNewDelhi @Lab_AmitSinghal @DBTIndia @ICMRDELHI
A new axis of pathogenicity in #tuberculosis involving #neutrophils and a strategy to improve TB prevention and control! @ICGEBNewDelhi @DBTIndia @Lab_AmitSinghal doi.org/10.7554/eLife.… @eLife
Deadline for Abstract Submission and Registration: 20th October 2024! #EMBOtuberculosis @ccmb_csir @ICGEBNewDelhi @Lab_AmitSinghal @DBTIndia @ICMRDELHI
Few additions: - Only student/trainie registration (INR 12,000) include sharing basis accomodation 🙂. - Travel and Child care grants from @EMBO - Flights from many major destinatins in Asia, EU, and US. Best connection by SQ, AirFrance and Emirates.
Official poster out 🤩 @EMBO #TB Host and Pathogen #Heterogenity #Hyderabad #India @ccmb_csir @idlabs_astar @PriscilleBrodin @EmboMolMed @ICGEBNewDelhi - 25 Invited speakers - 50 Abstracts - Flash talk - 12 Abstracts - Short talk - Travel grants - Reg. fee include accomodation
Exciting times ahead for Biotech innovation in India
Breaking News: Cabinet approves the BioE3 Policy! What's BioE3? 🧬 Biotechnology 💰 Economy 🌍 Environment 👥 Employment This policy aims to boost high-performance bio-manufacturing in India. Let's break it down for you! 🧵 #BioE3Policy #CabinetDecisions
India’s biotech sector is expected to experience substantial growth, with the bioeconomy projected to reach ₹24,000 Billion by 2030 and contribute 5-6% of the country’s GDP. Biomanufacturing will play a crucial role in this expansion, acting as a catalyst for economic…
The Bioenablers initiative introduces advanced facilities such as Bio-Artificial Intelligence Hubs for analyzing large-scale biological data, Biomanufacturing Hubs for turning R&D into bio based products, and Biofoundries for scaling biological engineering. #CabinetDecisions…
India’s new Biotech Policy outlines ambitious goals to foster innovation through support for R&D and entrepreneurship. It includes plans for establishing Biomanufacturing, Biofoundry, and Bio-AI Hubs, which will drive economic growth and job creation. The policy aims to set…
The focus on investing in the industrialization of biology is crucial for addressing urgent issues like climate change, food security, and health. By promoting sustainable and circular practices, this initiative aims to build a stronger and more resilient biomanufacturing…
Breaking News: Cabinet approves the BioE3 Policy! What's BioE3? 🧬 Biotechnology 💰 Economy 🌍 Environment 👥 Employment This policy aims to boost high-performance bio-manufacturing in India. Let's break it down for you! 🧵 #BioE3Policy #CabinetDecisions
Unofficial poster for the @EMBO #TB meeting. Great line up - from East to West. Registration deadline is 20th Oct, We have started getting applications. @TB_NewsDaily @CDC_TB @TBAlliance @gatesfoundation @institutpasteur @EmboMolMed @ICGEBNewDelhi @ccmb_csir
Excited to share the great line-up for the #EMBO #TB meeting @mayer_barber @MazDivangahi @oehlerslab @LuizCarvalhoLAB @ONeyrolles @ImmunologyKing @Ramande39667129 ....... Organized by @idlabs_astar @ICGEBNewDelhi @ccmb_csir meetings.embo.org/event/25-tuber…
After a gap of 4 years, the EMBO TB meeting returns, this time @ccmb_csir Hyderabad. Feb, 9-12, 2025 #Tuberculosis #heterogeneity #drugs #hostpathogeninteraction @ICGEBNewDelhi @DBTIndia @Lab_AmitSinghal @PriscilleBrodin meetings.embo.org/event/25-tuber…
#TB folks, EMBO "Host and Pathogen heterogeneity" meeting, Feb 2025 coming-soon.embo.org/gw25-02 @ICGEBNewDelhi @idlabs_astar @ccmb_csir @MazDivangahi @ONeyrolles @PriscilleBrodin @dhirajverma @mayer_barber @sheetalgandotra @Gaia_JExpMed @gatesfoundation @TBAlliance @NatureMicrobiol